Qiudi Huang

发表

Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis

Jian-hai Chen, Linghao Qin, Yugang Huang, 2020, Journal of Nanobiotechnology.

Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance

C. Schiffer, D. Bolon, J. Flynn, 2022, Nature Communications.

CKS1B as Drug Resistance-Inducing Gene—A Potential Target to Improve Cancer Therapy

Xiyong Yu, He Wang, Yi Zhou, 2020, Frontiers in Oncology.

pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer

Linghao Qin, Jinfang Li, Xiyong Yu, 2021, Journal of Nanobiotechnology.

A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression

Linghao Qin, Chengfeng Yue, He Wang, 2022, Acta pharmaceutica Sinica. B.

Enhanced Cytotoxicity to Lung Cancer Cells by Mitochondrial Delivery of Camptothecin.

Linghao Qin, Xiyong Yu, He Wang, 2023, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.